1. HER4 rs1595065 3'UTR Variant is a Possible Risk Factor for HER2 Positivity Among Breast Cancer Patients
   Bahareh Moradi et al, 2016, Thrita CrossRef
2. Down-regulation of microRNA-19b in hormone receptor-positive/HER2-negative breast cancer
   Elham Maleki et al, 2018, APMIS CrossRef
3. A genetic variant of miR-335 binding site in the ERBB4 3′-UTR is associated with prognosis of ovary cancer
   Ping Wei et al, 2018, J. Cell. Biochem. CrossRef
4. The miRNA binding site SNP in the 3′ UTR of NBS1 is inversely associated with breast cancer risk
   Nafezeh Ghanei et al, 2018, Journal of Cellular Immunotherapy CrossRef
5. ErbB4 3′-UTR Variant (c.*3622A>G) is Associated with ER/PR Negativity and Advanced Breast Cancer
   Maryam Tabatabian et al, 2018, Ind J Clin Biochem CrossRef
6. SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer
   A Shasttiri et al, 2018, British Journal of Biomedical Science CrossRef
7. Association of a potential functional mir-520f rs75598818 G > A polymorphism with breast cancer
   Marzieh Meshkat et al, 2018, J Genet CrossRef
8. Genetic and molecular biology of breast cancer among Iranian patients
   Meysam Moghbeli, 2019, J Transl Med CrossRef
9. The SNP rs3746444 within mir-499a is associated with breast cancer risk in Iranian population
   Shahrzad Kabirizadeh et al, 2016, Journal of Cellular Immunotherapy CrossRef
10. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer
    Guangbing Xiong et al, 2017, Cancer Letters CrossRef
11. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells
    Mahboobeh Forouzanfar et al, 2020, Stem Cell Res Ther CrossRef
12. microRNA‐related single‐nucleotide polymorphisms and breast cancer
    Farbod Bahreini et al, 2020, J Cell Physiol CrossRef
13. microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
    Tiziana Annese et al, 2020, Front. Oncol. CrossRef
14. DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells
    Mianjie Lin et al, 2021, Front. Oncol. CrossRef
15. Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population
    Wan-ping Wang et al, 2021 CrossRef
16. Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population
    Hale Güler Kara et al, 2021, Mol Biol Rep CrossRef
17. Genetic variations in 3′UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response
    Andrea Cumova et al, 2021 CrossRef
18. Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer
    Xunian Zhou et al, 2021, Molecular Therapy - Methods & Clinical Development CrossRef
19. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway
    Xiaochen Zan et al, 2022, Reprod Biol Endocrinol CrossRef
20. The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder
    Jaqueline Carvalho de Oliveira et al, 2022, Genes CrossRef
21. A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice
    Shingo Kawano et al, 2023, Cancer Science CrossRef
22. Sex-Biased CD3ζ 3ʹ-UTR SNP Increased Incidence Risk in Aplastic Anemia
    Lixing Guo et al, 2024, IJGM CrossRef